Investment Summary |
|
|---|---|
| Date | 2019-01-07 |
| Target | Atlantic Therapeutics |
| Sector | Medical Products |
| Investor(s) |
Andera Partners
Atlantic Bridge EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 69 of 123 |
| Sector: Medical Products M&A | 5 of 8 |
| Type: Venture M&A Deals | 18 of 28 |
| Country: Ireland M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-01 |
Erget
Neuilly-sur-Seine, France Erget is a specialist in claims appraisal on behalf of insurance companies. It intervenes in civil liability (operation, professional, products), in technical risks (breakage of machines, TRC, TRME) and in construction risks (DO, RCD, PUC) for companies. Erget was founded in 1986 and is based in Neuilly-sur-Seine, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-18 |
HighLife
Paris, France HighLife is a med‑tech company advancing a novel trans‑septal transcatheter mitral valve replacement (TMVR) system to treat mitral regurgitation. Its minimally invasive “valve‑in‑ring” TMVR technology replaces the mitral valve on a beating heart, offering a less‑traumatic alternative to open‑heart surgery. HighLife was founded in 2010 and is based in Paris, France. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 1.0B EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
Atlantic Bridge is a growth capital firm focused on mid-market technology businesses across Europe, the US, Middle East, and China. Specific areas of interest include machine learning, robotics, computer visioning, cloud, IoT and big data. Atlantic Bridge generally prefers 'domain-specific companies' as well as businesses that can benefit from transatlantic opportunities. Atlantic Bridge was formed in 2006 and is based in Dublin.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 34 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Venture M&A Deals | 21 of 25 |
| Country: Ireland M&A | 6 of 7 |
| Year: 2019 M&A | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-12 |
HyperGrid
Los Altos, California, United States HyperGrid is a HyperCloud Intelligent Cloud Management Platform (CMP) that provides powerful capabilities in a single pane of glass for cloud migration planning, cost management, continuous optimization, orchestration, governance, security, and compliance. HyperGrid was founded in 2016 and is based in Los Altos, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-20 |
Secondmind
Cambridge, United Kingdom Secondmind is an AI company that provides a machine learning–powered optimization platform for automotive engineering, helping OEMs and suppliers design, simulate, and calibrate complex vehicle systems faster and with less data. Secondmind was founded in 2016 and is based in Cambridge, United Kingdom. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 21 of 47 |
| Sector: Medical Products M&A | 9 of 14 |
| Type: Venture M&A Deals | 17 of 39 |
| Country: Ireland M&A | 2 of 5 |
| Year: 2019 M&A | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-01 |
T-knife Therapeutics
San Francisco, California, United States T-knife Therapeutics is a biopharmaceutical company developing next‑generation T‑cell receptor (TCR) engineered T cell therapies to treat solid tumors. T-knife Therapeutics was founded in 2018 and is based in San Francisco, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-11 |
SNIPR Biome
Copenhagen, Denmark SNIPR BIOME is pioneering a novel use of CRISPR/Cas technology to selectively and precisely eradicate target bacteria, while leaving the rest of the patient’s microbial community intact. SNIPR Biome was founded in 2017 and is based in Copenhagen, Denmark. |
Buy | - |
